Catalyst Event
AbbVie Inc (ABBV) · Other
From KEDI U.S. Medical AI Index (KUSMAI)
3/24/2026, 12:00:00 AM
Announced a multi-year partnership with Major League Baseball (MLB) to become its Official Pharmaceutical Partner, expanding the 'Striking Out Cancer' campaign.
Korean Translation
메이저리그(MLB)의 공식 제약 파트너가 되어 '스트라이킹 아웃 캔서' 캠페인을 확대하는 다년간의 파트너십을 발표함.
Related Recent Events
Recursion Pharmaceauticals Inc (RXRX) · Earnings Release
First quarter 2026 earnings release is scheduled for May 11, 2026, with analysts forecasting an EPS of approximately -$0.25. This event is critical for monitoring cash burn, justifying a medium importance estimate (expected 5-10% impact), forecasted
5/11/2026, 12:00:00 AM
Tempus AI Inc (TEM) · Earnings Release
As quarterly earnings are key volatility events for growth-stage AI companies, Tempus AI's Q1 2026 earnings release on May 5, 2026, is scheduled
5/5/2026, 12:00:00 AM
Eli Lilly and Co (LLY) · Earnings Release
Q1 2026 earnings release is scheduled; medium importance is estimated based on expected >=5% price impact.
4/30/2026, 12:00:00 AM
Alphabet Inc (GOOGL) · Earnings Release
Alphabet's Q1 2026 earnings release on April 23, 2026, with low importance estimated as no market reaction has occurred yet, expected.
4/23/2026, 12:00:00 AM
Intuitive Surgical Inc (ISRG) · Earnings Release
Q1 2026 earnings release and conference call for 2026-04-21 scheduled. Low importance is estimated due to the routine nature of the announcement scheduled.
4/21/2026, 12:00:00 AM
Eli Lilly and Co (LLY) · Other
FDA decision on oral weight-loss drug orforglipron is expected; high importance is estimated due to potential for >=10% price impact.
4/10/2026, 12:00:00 AM